Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey
- 1 March 2018
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 35 (3) , 103-108
Abstract
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new laparoscopic administration of chemotherapy for peritoneal metastasis (PM). PIPAC is repeated every 5th week, and seems to stabilize or improve quality of life, and might improve survival. So far, PIPAC has been well tolerated. With this paper, we aim to highlight a potential severe adverse reaction, as we describe the first cases of severe peritoneal sclerosis (SPS) caused by PIPAC. Patients with isolated PM were included in a prospective PIPAC protocol. Following insufflation of normothermic CO2, laparoscopy was performed at an intraabdominal pressure of 12 mmHg. After peritoneal lavage and quadrant biopsies of the PM, the patients were treated with oxaliplatin 92 mg/m2 (flowrate 0.5 ml/s, maximum pressure of 200 per square inch). Treatment related toxicity was evaluated after 2 weeks. Response was evaluated histologically by the Peritoneal Regression Grading Score (PRGS) and cytologically by analysis of the lavage fluid. In a series of 24 PIPAC patients treated with oxaliplatin, two patients developed SPS. Patient one had a mucinous adenocarcinoma of the appendix with PM, the mean PRGS was reduced from 2.75 to 1.75 during the course of therapy. Patient two had an appendiceal goblet cell carcinoid with a dominating mucinous adenocarcinoma component with PM, the mean PRGS was reduced from 2.00 to 1.67. Repeated applications of PIPAC with oxaliplatin can lead to SPS.Keywords
This publication has 27 references indexed in Scilit:
- Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for EfficacyAnnals of Surgical Oncology, 2013
- High Pressure Enhances the Effect of Hyperthermia in Intraperitoneal Chemotherapy With OxaliplatinAnnals of Surgery, 2012
- Description of a novel approach for intraperitoneal drug delivery and the related deviceSurgical Endoscopy, 2012
- Encapsulating peritoneal sclerosis: the state of affairsNature Reviews Nephrology, 2011
- Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapyCancer, 2010
- Different Aspects of Peritoneal Damage: Fibrosis and Sclerosis2009
- High Intra-abdominal Pressure Enhances the Penetration and Antitumor Effect of Intraperitoneal Cisplatin on Experimental Peritoneal CarcinomatosisAnnals of Surgery, 2006
- Sclerosing Encapsulating Peritonitis (SEP) as a Delayed Complication of Continuous Hyperthermic Peritoneal Perfusion (CHPP): Report of a CaseSurgery Today, 2003
- Peritoneal carcinomatosis from colorectal cancerBritish Journal of Surgery, 2002
- Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administrationAnti-Cancer Drugs, 1996